$100 Invested In This Stock 20 Years Ago Would Be Worth $6,000 Today

Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 15.45% on an annualized basis producing an average annual return of 22.72%. Currently, Regeneron Pharmaceuticals has a market capitalization of $87.68 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $6,000.82 today based on a price of $807.69 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 20 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.